AZD6244
D1532C00067
Phase 1 small_molecule completed
Quick answer
AZD6244 for Neoplasms, is a Phase 1 program (small_molecule) at AstraZeneca with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca
- Indication
- Neoplasms,
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed